Concepedia

Gokul Swaminathan

GS

Statistics

Publications

12

Citations

517

H-Index

11

Active since

2012

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Drexel University

Institute for Molecular Medicine

University of Pennsylvania

Gokul Swaminathan is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in life sciences, immunology, and vaccinology.

ORCID

Publications per year

2012–2023

12

Publications

12

A novel lipid nanoparticle adjuvant significantly enhances B cell and T cell responses to sub-unit vaccine antigens

Gokul Swaminathan, Elizabeth Thoryk, Steven Meschino et al. · Vaccine · 2015 · 120 citations

, , +16

A Role for microRNA-155 Modulation in the Anti-HIV-1 Effects of Toll-Like Receptor 3 Stimulation in Macrophages

Gokul Swaminathan, Fiorella Rossi, Luz‐Jeannette Sierra et al. · PLoS Pathogens · 2012 · 108 citations · Full text

, , +17

A Tetravalent Sub-unit Dengue Vaccine Formulated with Ionizable Cationic Lipid Nanoparticle induces Significant Immune Responses in Rodents and Non-Human Primates

Gokul Swaminathan, Elizabeth Thoryk, Jeffrey S. Smith et al. · Scientific Reports · 2016 · 77 citations · Full text

, , +17

Inhibiting Early-Stage Events in HIV-1 Replication by Small-Molecule Targeting of the HIV-1 Capsid

Sandhya Kortagere, Navid Madani, Marie K. Mankowski et al. · Journal of Virology · 2012 · 75 citations · Full text

, , +16

Adenovirus Delivered Short Hairpin RNA Targeting a Conserved Site in the 5′ Non-Translated Region Inhibits All Four Serotypes of Dengue Viruses

Anil Babu Korrapati, Gokul Swaminathan, Aarti Singh et al. · PLoS neglected tropical diseases · 2012 · 27 citations · Full text

, , +17

1–5 of 12